Product Name: Human TWEAKR Antibody (Enavatuzumab, Research Use)
Catalog Number: NBR-0298
Target Name: TWEAKR
Trade Name: Enavatuzumab
Antibody Drug Description: Enavatuzumab is a humanized IgG1 anti-TWEAK receptor monoclonal antibody that was evaluated in a phase I clinical study for the treatment of solid malignancies. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: TWEAKR
Synonyms: CD266; FN14; TweakR
Target Description: Receptor for TNFSF12/TWEAK. Weak inducer of apoptosis in some cell types. Promotes angiogenesis and the proliferation of endothelial cells. May modulate cellular adhesion to matrix proteins.
Ensembl: ENSG00000006327
Uniprot: Q9NP84